2-Bromo-1,3-diphenyl-propane-1,3-dione, 97.0%, 1g

(4-Formyl-2-methoxyphenoxy)acetic acid, 100mg

tert-Butyl 4-[(2-nitrophenylamino)methyl]piperidine-1-carboxylate, 95.0%, 1g

1,2-Pyrrolidinedicarboxylic acid, 4-[[[[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]amino]carbonyl]oxy]-, 2-methyl 1-(phenylmethyl) ester, (2S,4R)-, 98%, 250mg

2-Isobutoxyacetic acid, 98%, 1g

5-Bromo-4-chloro-1H-pyrazole, 95+%, 5g

Ethyl 2-(benzo[d]thiazol-2-yl)-2-oxoacetate, 95%, 250mg

3-(3-bromophenyl)-3'-carboethoxypropiophenone, 97.0%, 1g

2,6-Dimethyl-4-methoxybenzeneboronic acid, 97.0%, 5g

Ethyl 2-ethoxyacetate, 95.0%, 5g

EDTA dipotassium salt dihydrate, min. 99%, for synthesis, 500 g, plastic packaging.

3-ETHYNYLPIPERIDIN-3-OL HCL, 95%, 100mg

Methyl 2,6-dichloro-5-methoxypyrimidine-4-carboxylate, 95.0%, 25g